Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Australia

 

KKR going ahead with Ramsay bid

Private equity firm KKR has reconfirmed its AU$88 per share offer for multinational hospital group Ramsay Health Care after completing due diligence on the company last week, HBI understands. It will now begin due diligence on Ramsay’s 52.79% stake in its subsidiary Ramsay Générale de Santé, which could take another few weeks. The deal still has to be approved by the French Competition Authority (FCA), which could take issue over the fact that KKR owns a 43% stake in Elsan, Ramsay Santé's largest competitor in France.

Bupa Australia accuses Ramsay of strategic price hikes as Ramsay terminates partnership

The Australian branch of multinational hospital giant Ramsay Health Care has terminated its partnership with insurer Bupa, meaning Bupa-insured patients in Australia will have to pay out-of-pocket for its care. Bupa Australia subsequently accused Ramsay of “unreasonably high" price increases, claiming this was done to increase the group’s value in light of its on-going sale process. Meanwhile, Ramsay has reported poor financial results and analysts from investment bank Citigroup have said limited additional value could be squeezed out of the group, and that a higher bid than KKR's is therefore unlikely. 

Lim and others eye up IVIRMA

Singapore billionaire Peter Lim is said to be in talks to buy IVIRMA, the Euro-American fertility player where big private equity is expected to bid high. HBI understands other bidders may include KKR, Carlyle and Cinven.

Covid disruptions reduce Ramsay profits by 30%

Australian multi-national hospital group Ramsay saw steady sales but sharply decreasing earnings in the last six months of 2021. The company says this was due to Covid disruptions, whilst underlying demand for healthcare services remains strong.

Virtus takeover could lead to M&A push in Europe

Australia-based listed fertility specialist Virtus Health, which also has a footprint in Ireland, Denmark, the UK and Singapore, is the subject of a takeover bid. HBI speaks to an operator source to find out more about the prospects of one of the largest international fertility groups delisting.

Ramsay share price slumps after elective surgery ban in Australia

International hospital operator Ramsay’s share price fell 5.7% last Thursday, following the announcement that the Australian state of Victoria was reintroducing restrictions on non-urgent elective surgeries. On Friday, New South Wales followed suit.

HBI Interview: Carlos Nueno, President, International, Teladoc 

How fast is the world outside America adopting telehealth and digital care in all its forms? Who better to ask than Carlos Nueno, president International for Teladoc Health, which ties with Ping An from China for the title of the world’s largest telehealth operator. So, what new business models are being rolled out and when? And how are countries adopting the new technology?

US homecare tech specialist buys Home Instead

US-based homecare tech specialist Honor Technology has acquired Home Instead, the global leader of franchise homecare services. The deal creates a global homecare group worth more than $2.1 billion in homecare revenue.  HBI chats with sources including Home Instead's UK CEO to find out what the deal means for markets outside of the United States.

Find Us